Boston Scientific Corporation (BSX) Shares are Down -0.83%

Boston Scientific Corporation (BSX) : During the past 4 weeks, traders have been relatively bearish on Boston Scientific Corporation (BSX), hence the stock is down -1.07% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -0.17% relative to the S&P 500. The 4-week change in the price of the stock is -1.28% and the stock has fallen -0.83% in the past 1 week.

For the current week, the company shares have a recommendation consensus of Buy. The stock has recorded a twenty day Moving Average of 0.16% and the fifty day Moving Average is 1.46%. Boston Scientific Corporation is up 6.16% in the last three month period. Year-to-Date the stock performance stands at 29.99%.

Boston Scientific Corporation (BSX) : The highest level Boston Scientific Corporation (BSX) is projected to reach is $30 for the short term and the lowest estimate is at $20. The consolidated price target from 18 rating analysts who initiate coverage on the stock is $26.08 and the possibility the share price can swing is $2.99.


Boston Scientific Corporation (NYSE:BSX): stock turned positive on Friday. Though the stock opened at $23.85, the bulls momentum made the stock top out at $24.0389 level for the day. The stock recorded a low of $23.695 and closed the trading day at $23.97, in the green by 0.84%. The total traded volume for the day was 6,744,311. The stock had closed at $23.77 in the previous days trading.

Boston Scientific Corporation develops, manufactures and markets medical devices. The Company offers its products by seven core businesses: Interventional Cardiology, which includes Drug-Eluting Coronary Stent Systems, Intravascular Imaging devised and Coronary Technology products, such as guide wires, guide catheters, and balloon catheters, among others; Peripheral Interventions (PI), which include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters; Cardiac Rhythm Management (CRM), which include implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities; Electrophysiology (EP), which include steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories; Endoscopy, which includes Spyglass System, WallFlex Colonic Stents, Resolution Clip, and Expect Aspiration Needle, among others; Urology and Womens Health, and Neuromodulation.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.